Brief: Jupiter Neurosciences Says Patient Enrollment Underway In Phase 2A Reset Trial In Parkinson's Disease
27/05/2026 12:51
BRIEF-Jupiter Neurosciences Says Patient Enrollment Underway In Phase 2A Reset Trial In Parkinson's Disease May 27 (Reuters) - Jupiter Neurosciences Inc JUNS.O:
ANNOUNCES PATIENT ENROLLMENT UNDERWAY IN PHASE 2A RESET TRIAL IN PARKINSON’S DISEASE
Source text: ID:nGNX9JPbzg
Further company coverage: JUNS.O
((Reutersbriefs@thomsonreuters.com;))